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Introduction: Mouth and genital ulcers with inflamed cartilage (MAGIC) syndrome is a rare overlap syndrome that
includes features characteristic of both Behçet’s disease (BD) and relapsing polychondritis (RP).
Case description: A 30-year-old female complained of lower abdominal pain and bloody stools during medical
treatment for RP. Total colonoscopy revealed oval-shaped deep ulcers on the terminal ileum similar to those of
intestinal BD. After performing the ileocecal resection, both RP and gastrointestinal lesions relapsed, but improved
with infliximab treatment.
Discussion and evaluation: During medical treatment for RP, we experienced a rare case with ileocecal ulcers
similar to intestinal BD. Although our case did not meet the diagnosis criteria of intestinal BD because of the lack of
BD’s major clinical symptoms, intestinal lesions shared quite similar features with intestinal BD. Our case could
possibly be a rare subtype of MAGIC syndrome that had the features characteristic of both intestinal BD and RP.
Conclusions: We described a rare case of ileocecal ulcers without any BD symptoms but accompanied by RP,
possibly be a subtype of MAGIC syndrome.
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Behçet’s disease (BD) is a chronic relapsing inflammatory
disease with multiorgan system involvement which is
clinically characterized by oral aphthae, genital ulcers,
cutaneous lesions, and ophthalmologic manifestations.
BD patients are common in Asia, the Middle East and
the Mediterranean regions; however, it is uncommon in
Western countries (Sakane et al. 1999). It is reported
that 3–16% of the patients with BD have gastrointestinal
(GI) tract involvement (Hisamatsu et al. 2014). BD pa-
tients with GI lesions are subcategorized as intestinal
BD because these patients often have severe GI compli-
cations and a poor prognosis. In typical cases of intestinal
BD, patients often develop an oval-shaped deep ulcer in
the ileoceacal lesion which sometimes causes massive
bleeding and perforation. Recently, the consensus state-
ments for the diagnosis and management for intestinal* Correspondence: yoko0330@med.tohoku.ac.jp
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Experts (Hisamatsu et al. 2014; Kobayashi et al. 2007). In
this statement, diagnostic criteria and therapeutic strategy
are mentioned. According to the statement, besides GI le-
sions, BD symptoms such as mouth, eye, skin, and genital
lesions are necessary for the diagnosis of intestinal BD
(Kobayashi et al. 2007).
Relapsing polychondritis (RP) is a rare and chronic
disease characterized by recurrent inflammation epi-
sodes of the cartilaginous tissue and other proteoglycan-
rich tissues (McAdam et al. 1976; Damiani and Levine
1979). Patients with RP have diverse symptoms in the
auricle, nose, eyes, tracheal cartilage, joints, heart, and
blood vessels. The etiology of RP is unknown, but an auto-
immune origin has been hypothesized. Approximately 30%
of the cases are associated with other auto-immune dis-
eases (McAdam et al. 1976). Criteria for diagnosis, sug-
gested by McAdam et al. (1976), include three or more of
the following clinical features: 1) bilateral auricular chondri-
tis, 2) nonerosive seronegative inflammatory polyarthritis,
3) nasal chondritis, 4) ocular inflammation, 5) respiratoryis an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
Table 1 Laboratory data on the first visit
Peripheral blood Blood chemistry
WBC 10300/μl AST 27 IU/l
RBC 3.2 × 106/μl ALT 27 IU/l
Hb 8.7 g/dl ALP 199 IU/l
Hct 27.2% Γ-GTP 20 IU/l
MCV 85.1 fl LDH 131 IU/l
MCH 27.1 pg T-Bil 0.3 mg/dl
MCHC 31.8% CPK 8 IU/l
PLT 47.7 × 104/μl TP 5.9 g/dl
Alb 2.9 g/dl
Serological test BUN 14 mg/dl





WBC white bold cell, RBC red blood cell, Hb hemoglobin, Hct hematocrit, MCV mean
corpuscular volume, MCH mean corpuscular volume, MCHC mean corpuscular
hemoglobin concentration, Pl tplatelets, AST aspartate aminotransferese, ALT
alanineaminotransferase, ALP alkaline phosphatase, γ-GTP γ-glutamyltransferase,
LDH lactate dehydrogenase, T-Bil total bilirubin, CPK ccreatine phosphokinase, TP
total protein, Alb albumin, BUN blood urea nitrogen, Cr creatinine, Na sodium, K
potassium, Cl chloride, Ca calcium, CRP C-reactive protein.
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patible histological features in a cartilage biopsy specimen.
Mouth and genital ulcers with inflamed cartilage (MAGIC)
syndrome is a rare overlap syndrome that includes fea-
tures characteristic of both BD and RP (Firestein et al.
1985). Although there have been no established diagnosis
criteria, both mucosal symptoms (oral aphthae or genital
ulcers) and cartilage inflammation are thought to be ne-
cessary for the diagnosis of MAGIC syndrome as Firestein
et al. initially described in 1985 (Firestein et al. 1985).
Most of the cases reported as MAGIC syndrome had no
GI lesions. However, a few cases of MAGIC syndrome
with GI lesions besides mucosal lesions and cartilage in-
flammation (Firestein et al. 1985; Imai et al. 1997; Kotter
et al. 2006; Minami et al. 2009) have been reported. Until
now, there has been no other case report of RP with typ-
ical Behçet’s GI lesions without any mucosal lesions.
During medical treatment for RP, we experienced a
rare case with ileocecal ulcers similar to intestinal BD.
Although our case did not meet the diagnosis criteria of
intestinal BD because of the lack of BD’s major clinical
symptoms, intestinal lesions shared quite similar features
with intestinal BD. Our case could possibly be a rare
subtype of MAGIC syndrome that had the features char-
acteristic of both intestinal BD and RP. In this report,
we have reported the case precisely and made a discus-
sion focused on the diagnosis and treatment with litera-
ture review.
Case presentation
A 30-year-old female with a fever, scleritis, and auricular
pain for a duration of 3 months was examined. She was
finally diagnosed with RP from her symptoms, auricle bi-
opsy and response to corticosteroid therapy according to
the proposed diagnostic criteria (McAdam et al. 1976;
Damiani and Levine 1979). She frequently took non-
steroidal anti-inflammatory drugs (NSAIDs) along with
predonisolone for pain control. Subsequently, she expe-
rienced episodes of lower abdominal pain 2 months after
the initial diagnosis of RP. Although her abdominal symp-
toms temporally subsided with steroid pulse therapy, the
abdominal pain relapsed and the bloody stools as well as
anemia emerged after terminating steroid pulse therapy.
As a result, we started to investigate her abdomen and GI
tract. Laboratory tests revealed an increased inflammatory
response (white blood cells 10,300/μl; C-reactive protein,
5.4 mg/dl), hypoalbuminemia (total protein, 5.9 g/dl, albu-
min, 2.9 g/dl), and anemia (red blood cells, 3.20 × 106/μl,
hemoglobin, 8.7 g/dl, hematocrit, 27.2%) (Table 1). Ab-
dominal contrast-enhanced computed tomography (CT)
scan revealed thickening of the ileocecal wall, and positron
emission tomogaraphy (PET) revealed accumulation in
the intestinal tract at the terminal ileum. Total colonos-
copy (TCS) revealed oval-shaped deep ulcers on theterminal ileum with deformity and destruction of the ileo-
cecal valve (Figure 1). In addition, reddish edematous mu-
cosa and ulcers were detected in the oral side of the
ileum. Biopsy specimens taken from the terminal ileum
showed nonspecific inflammatory findings. There were no
abnormal findings in her large intestinal mucosa and
upper GI tracts. We highly suspected the possibility of in-
testinal BD from the characteristic endoscopic findings,
but the case did not meet the diagnostic criteria because
of lacking the major BD symptoms such as oral aphthoid
ulcers, eye symptoms, skin lesions or genital ulcers. In
addition, other diseases such as NSAIDs-induced enteritis
were not completely denied; therefore, we selected a con-
servative therapy and planned a close follow-up. After
restricting food and NSAIDs from the initial TCS, slight
improvements were observed in her abdominal symptoms.
However, no significant change was evident on colonoscopy
performed 4 weeks after the initial TCS. Differential diag-
noses included intestinal BD, Crohn’s disease, NSAIDs-
induced enteritis, malignant lymphoma, and infectious
colitis such as cytomegalovirus colitis or enteric tubercu-
losis. However, the test results, including a biopsy, culture,
and various imaging tests did not provide a definitive diag-
nosis. We decided to perform surgery in order to make
a definite diagnosis and avoid the GI perforation because
of the presence of deep and active ulcers. An ileocecal re-
section was performed 5 weeks after the initial TCS. Gross
findings of the resected specimen showed that the ileocecal
Figure 1 Total colonoscopy (TCS) revealed oval-shaped deep ulcers on the terminal ileum with deformity and destruction of the
ileocecal valve.
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Furthermore, large and small ulcers were diffusely-scattered
on the ileal mucosa, from the ileocecal valve to 30 cm on
the oral side (Figure 2). Histological examination revealed
ulcer formation with destruction of muscularis propria.
The ulcer base was rather flat and showing involvement ofFigure 2 Gross findings from the resected specimen. (A and B) The ile
(C) Large and small ulcers were diffusely-scattered on the ileal mucosanonspecific chronic inflammation with fibrotic change.
The mucosa around the ulcers remained relatively normal
in structure (Figure 3). There were no specific findings
such as granulomas, CMV-infected cells, vasculitis or
thrombus formation; thus, we remained to believe intes-
tinal BD as the diagnosis.ocecal valve was highly deformed and destroyed by deep ulcers.
, from the ileocecal valve to 30 cm the oral side.
Figure 3 Pathological findings from the resected specimen. (A and B) There was nonspecific inflammation in the ulcers. There were no
specific findings such as granulomas, CMV-infected cells, vasculitis or thrombus formation. (C) The mucosa around the ulcers remained relatively
normal in structure. (Hematoxylin and eosin stain).
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followed her progress on an outpatient basis while taper-
ing her prednisolone dosage. However, RP symptoms such
as fever, scleritis, and auricular pain relapsed 5 months
after the operation, in addition to the recurrence of ab-
dominal pain and watery diarrhea. This led us to perform
TCS which revealed multiple deep and round ulcers de-
veloping at the anastomotic site. We also observed mul-
tiple erosions and aphthae on the oral side of the small
intestine and large bowel from the ascending colon to the
rectum (Figure 4). We initiated infliximab (IFX) adminis-
tration, which has been reported to be effective against
both RP and BD. After the administration of IFX, her
cartilaginous and abdominal symptoms dramatically im-
proved. A follow-up TCS was performed at the end of the
fourth administration of IFX. We identified ulcer scars at
the anastomosis site and inflammation of the large intes-
tine improved (Figure 5). We recognized that both RP and
BD were responsive to IFX administration. Currently as
an outpatient, she is regularly receiving IFX treatment and
continues to remain in good health.
Discussion
Intestinal BD is a subcategory of BD that develops charac-
teristic inflammation in the GI tracts. Although some
cases involve the esophagus or small intestine (Hisamatsu
et al. 2014), patients often have an oval-shaped deep ulcer
in the ileocecal lesion. Patients with intestinal BD have
symptoms such as abodominal pain, bloody stools and
diarrhea. Sometimes massive bleeding or perforation can
occur which leads to a poor prognosis. Our patient alsohad lower abdominal pain and bloody stool during RP
treatment that were consistent with intestinal BD symp-
toms. As for the diagnosis of intestinal BD, Japanese ex-
pert’s committee proposed the diagnosis criteria initially
in 2007 (Kobayashi et al. 2007). Recently, they published
the 2nd edition of this statement (Hisamatsu et al. 2014).
According to their statement, the diagnosis of intestinal
BD could be made if the patient meets the following
criteria: A) There is a typical oval-shaped large ulcer in
the terminal ileum, and clinical findings meet the diagnos-
tic criteria of BD or, B) There are ulcerations or inflamma-
tion in the small or large intestine, and clinical findings
meet the diagnostic criteria of BD. Furthermore, acute
appendicitis, infectious enteritis, tuberculosis, Crohn’s
disease, nonspecific colitis, drug-associated colitis and
other diseases that mimic intestinal BD should be ex-
cluded by clinical findings, radiology, and endoscopy.
Our case developed deep oval-shaped ulcers in the ter-
minal ileum resembling those of intestinal BD. Gross find-
ings of the resected specimen showed that ileocecal
valve was highly deformed and destroyed by deep ulcers.
Histological examination revealed that nonspecific in-
flammation and ulcers had reached the muscularis pro-
pria. There were no specific findings such as granulomas,
CMV-infected cells, vasculitis or thrombus formation.
These GI findings itself were quite similar to those of in-
testinal BD. However, we could not confirm a diagnosis
of intestinal BD because of the lack of oral aphthoid
ulcers, eye symptoms, skin lesions or genital ulcers which
were necessary for the diagnosis. We believed there
was a high possibility that the present case could be
Figure 4 Total colonoscopy revealed multiple deep and round ulcers developing on the anastomotic site, and multiple erosions and
aphthae were observed on the oral side of the small and large intestine.
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ulcer”, which is defined as deep ileocecal ulcers difficult to
distinguish from intestinal BD but lacks the other clinical
symptoms of BD, has been advocated in Japan (Murano
et al. 2011). Although it is an inconclusive discussion,Figure 5 Total colonoscopy shows significant improvement of the ulcthe simple ulcer has been considered to be related to
intestinal BD.
RP is a rare and chronic disease characterized by recur-
rent inflammation episodes of cartilaginous tissue and other
proteoglycan-rich tissues. RP is a multisystem autoimmuneers on the anastomosis site.
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though some cases of RP accompanied by ulcerative colitis
was reported (Firestein et al. 1985; Benito Calavia et al.
1997; Kawano et al. 2001), GI symptoms are uncommon
in RP (Firestein et al. 1985) and there have been few re-
ports of intestinal BD with RP. The criteria for the diagno-
sis of RP were proposed by McAdam et al. (1976), which
include three or more of the following clinical fea-
tures: 1) bilateral auricular chondritis, 2) nonerosive sero-
negative inflammatory polyarthritis, 3) nasal chondritis,
4) ocular inflammation, 5) respiratory tract chondritis,
and 6) audiovestibular damage, with compatible histo-
logical features in a cartilage biopsy specimen. These cri-
teria were slightly expanded by Damiani and Levine (1979)
to include reaction to treatment with corticosteroids or
dapsone (Damiani and Levine 1979). Our patient had
scleritis, auricular pain, and vertigo. Because these clinical
findings, auricle biopsy results and the response to cor-
ticosteroid fulfilled the above diagnostic criteria, we were
able to confirm our diagnosis of RP.
MAGIC syndrome was initially described by Firestein
et al. (1985). MAGIC syndrome is defined as an overlap
syndrome that includes features characteristic of both BD
and RP. Although a few authors suggest that MAGIC syn-
drome is not a disease entity but merely the association of
BD with polychondritis (Kotter et al. 2006; Kotter 2006),
many authors support the concept of this syndrome (Imai
et al. 1997; Orme et al. 1990; Kim et al. 2005; Caceres
et al. 2006; Nanke et al. 2006; Hidalgo-Tenorio et al. 2008;
Mekinian et al. 2009; Geissal and Wernick 2010; Gertner
2004). They suggest that the similarities in the clinical
manifestations and pathological findings in BD and RP lead
a common pathogenetic pathway, so that there is a close
relationship between both diseases (Orme et al. 1990; Kim
et al. 2005; Hidalgo-Tenorio et al. 2008; Mekinian et al.
2009; Gertner 2004).
The definite diagnosis criteria of MAGIC syndrome
have not been established. However, both mucosal symp-
toms (oral aphthae or genital ulcers) and cartilage inflam-
mation are thought to be necessary for diagnosis according
to the first descriptions by Firestein et al. (1985). It is a veryTable 2 Summary of the cases of MAGIC syndrome with GI le
Case no. Author Age/gender
Chondritis Chond
1 Firestein et al. (1985) 59, M Auricular chondritis (+)
2 Imai et al. (1997) 39, F Auricular chondritis (+)
3 Kotter et al. (2006) 59, M Auricular chondritis (+)
4 Minami et al. (2009) 30, M Auricular chondritis, (−)
5 Our case 30, F Auricular chondritis,
nasal chondritis
(−)uncommon disorder, and until now, only 24 cases have
been reported (Firestein et al. 1985; Imai et al. 1997; Kotter
et al. 2006; Minami et al. 2009; Orme et al. 1990;
Kim et al. 2005; Caceres et al. 2006; Nanke et al. 2006;
Hidalgo-Tenorio et al. 2008; Mekinian et al. 2009; Geissal
and Wernick 2010; Gertner 2004; Le Thi et al. 1993;
Fernandez-Monras et al. 1997; Ng et al. 2007). All of
the 24 cases had both mucosal symptoms and cartil-
age inflammation, and met the Firestein’s definition. Five
out of the 24 cases were reported to have colitis or ileoce-
cal ulcers (Firestein et al. 1985; Imai et al. 1997; Kotter
et al. 2006; Minami et al. 2009). In these 5 cases, 2 cases
had ileocecal ulcers that were thought to be a typical GI
lesion of intestinal BD (Table 2). Therefore, patients with
MAGIC syndrome who have characteristic ileoceacal ul-
cers consistent with intestinal BD are rare, but do exist.
Until now, there has been few report of a RP with intes-
tinal BD that had no mucosal lesions. Our patient did not
present symptoms such as oral and genital ulcers, but had
ileocecal ulcers consistent with intestinal BD during the
treatment for RP. Our case completely met the diagnostic
criteria for RP, and had a typical GI lesion similar to intes-
tinal BD. However, the case did not completely meet the
MAGIC syndrome definition, because she had no mucosal
lesions. It remains possible that the using corticosteroid
for RP might cover her mucosal symptoms. So we con-
sider that our case could possibly be a rare subtype of
MAGIC syndrome that had the complete features of RP
and partial characteristics of intestinal BD.
In conventional therapy for intestinal BD, 5-aminosalicylic
acid (5-ASA) systemic corticosteroid, and immunosup-
pressive agents have been used (Hisamatsu et al. 2014).
However, many patients become refractory to these drugs.
Recently, the efficacy of anti-tumor necrosis factor (TNF)α
antibodies, such as infliximab and adalimumab was re-
ported (Sfikakis et al. 2001; Travis et al. 2001; Hassard
et al. 2001; Kram et al. 2003; Ju et al. 2007; Byeon et al.
2007; Naganuma et al. 2008; Iwata et al. 2011; Kinoshita
et al. 2013). The 2nd edition of the consensus statement of
the Japanese Experts Committee described that infliximab
and adalimumab should be considered as a standardsions
Clinical features





(+) (−) (−) Duodenal ulcer,
intestinal fistula
(+) Keratoiritis Erythema nodosum Colitis
(−) Scleritis (−) Aphthous colitis
(+) Scleritis (−) Ileocecal ulcer
(−) Scleritis (−) Ileocecal ulcer
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the treatment for RP, various drugs including corticosteroid,
NSAIDs, colchicine, hydroxychloroquine, dapsone, metho-
trexate, azathioprine, cyclophoshamide, and cyclosporine
have been used (Kemta Lekpa et al. 2012). In many cases,
corticosteroid can be effective; however, not all patients
respond adequately. In recent years, several patients were
reported to be treated with infliximab successfully (Kemta
Lekpa et al. 2012). Pharmacological treatment options for
MAGIC syndrome are comprised of NSAIDs, colchicines,
corticosteroids, immunosuppressants, and biologics, but
there is no specific treatment. To date, only three cases of
MAGIC syndrome treated with anti-TNFα have been re-
ported (Hidalgo-Tenorio et al. 2008; Mekinian et al. 2009;
Geissal and Wernick 2010). They were all treated with
IFX (3 ~ 5 mg/kg) and two of the cases have continued to
be in remission.
Our case was corticosteroid dependent and refractory.
Although both RP symptoms and GI symptoms improved
during steroid pulse therapy before the operation, the
symptoms relapsed after stopping the therapy. Further-
more, after the ileocecal resection, both RP and GI lesions
relapsed at the same time when reducing the prednisol-
one dosage. As mentioned above, infliximab has been
reported to be effective to RP, intestinal BD and MAGIC
syndrome. As a result, we administrated infliximab in
order to avoid the continuous high dose usage of ste-
roids. The patient dramatically demonstrated good re-
sponse to infliximab. Examples of administering biologic
therapies such as infliximab to treat patients with intes-
tinal BD, RP, and MAGIC syndrome have gradually in-
creased (Hisamatsu et al. 2014; Kobayashi et al. 2007;
Hidalgo-Tenorio et al. 2008; Mekinian et al. 2009; Geissal
and Wernick 2010; Kemta Lekpa et al. 2012; Hatemi et al.
2012). Considering the good response to infliximab in
other cases and ours, TNFα may play a fundamental role
in MAGIC syndorome. Further investigations are neces-
sary to establish the appropriate therapeutic strategy for
MAGIC syndrome.
Conclusions
We described a rare case of ileocecal ulcers without any
BD symptoms but accompanied by RP, possibly be a
subtype of MAGIC syndrome. Additional cases and fur-
ther investigation are required to clarify the pathogenesis
of this rare syndrome.
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